Literature DB >> 18026067

Reliability of clinical spasticity measurements in patients with cervical spinal cord injury.

Piotr Tederko1, Marek Krasuski, Julita Czech, Agnieszka Dargiel, Iwona Garwacka-Jodzis, Anna Wojciechowska.   

Abstract

BACKGROUND: The Modified Ashworth Scale (MAS) is the most popular clinical measure of spasticity. Other clinical signs of spasticity include hyperactive tendon reflexes, myoclonus and Babinski sign.
PURPOSE: To assess reliability of the MAS with myoclonic and tendon reflex examination (MTR) in patients with spinal cord injury (SCI).
MATERIAL AND METHODS: 30 patients (16 with complete and 14 with incomplete neural deficit) who sustained cervical SCI 4-66 months prior to the study. Mean age 33,9 years (SD=14,7). 6 independent observers rated MAS and MTR in each patient.
RESULTS: Poor interrater reliability of MAS (ICC=0.56) and good reliability of MTR (ICC=0.81) were demonstrated. There was satisfactory to good correlation between averaged MAS rates (Pearson coefficient 0.67-0.9). MAS reliability was lower in the lower limbs and when joint contractures were present. Significantly (p<0.01) lower MAS repeatability was noted in subjects below 30 years of age. There was a positive correlation between patient functional status and MAS repeatability. MAS reliability did not depend on mean muscle tone, sex, or time since injury.
CONCLUSIONS: Although MAS does not reliably assess the tone of individual muscle groups in patients with SCI, it may be helpful in assessing overall muscular tone. MAS repeatability is lower in younger patients. MAS is inappropriate for the assessment of patients with joint contractures. An examination of tendon reflexes, myoclonus and the Babinski sign is reliable in SCI patients

Entities:  

Mesh:

Year:  2007        PMID: 18026067

Source DB:  PubMed          Journal:  Ortop Traumatol Rehabil        ISSN: 1509-3492


  7 in total

1.  Quantitative evaluations of ankle spasticity and stiffness in neurological disorders using manual spasticity evaluator.

Authors:  Qiyu Peng; Hyung-Soon Park; Parag Shah; Nicole Wilson; Yupeng Ren; Yi-Ning Wu; Jie Liu; Deborah J Gaebler-Spira; Li-Qun Zhang
Journal:  J Rehabil Res Dev       Date:  2011

2.  Reliability of the Modified Ashworth Scale and Modified Tardieu Scale in patients with spinal cord injuries.

Authors:  P Akpinar; A Atici; F U Ozkan; I Aktas; D G Kulcu; A Sarı; B Durmus
Journal:  Spinal Cord       Date:  2017-05-09       Impact factor: 2.772

3.  Retrospective review on effectiveness of high-amplitude penile vibratory stimulation for conservative sperm retrieval in anejaculatory men with spinal cord injury: an Asian case series.

Authors:  Akmal Hafizah Zamli; Nor Azira Ismail; Kuo Ghee Ong
Journal:  Spinal Cord Ser Cases       Date:  2016-04-07

4.  Development of a Haptic Elbow Spasticity Simulator (HESS) for improving accuracy and reliability of clinical assessment of spasticity.

Authors:  Hyung-Soon Park; Jonghyun Kim; Diane L Damiano
Journal:  IEEE Trans Neural Syst Rehabil Eng       Date:  2012-05-02       Impact factor: 3.802

5.  Gait characteristics, range of motion, and spasticity changes in response to massage in a person with incomplete spinal cord injury: case report.

Authors:  Christine Manella; Deborah Backus
Journal:  Int J Ther Massage Bodywork       Date:  2011-03-30

6.  The effect of extracorporeal shock wave therapy in acute traumatic spinal cord injury on motor and sensory function within 6 months post-injury: a study protocol for a two-arm three-stage adaptive, prospective, multi-center, randomized, blinded, placebo-controlled clinical trial.

Authors:  Iris Leister; Rainer Mittermayr; Georg Mattiassich; Ludwig Aigner; Thomas Haider; Lukas Machegger; Harald Kindermann; Anja Grazer-Horacek; Johannes Holfeld; Wolfgang Schaden
Journal:  Trials       Date:  2022-04-01       Impact factor: 2.279

7.  Reduction in post-spinal cord injury spasticity by combination of peripheral nerve grafting and acidic fibroblast growth factor infusion in monkeys.

Authors:  Wei-Ming Sun; Chao-Lin Ma; Jiang Xu; Ji-Ping He
Journal:  J Int Med Res       Date:  2021-06       Impact factor: 1.671

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.